g. sirin Et Al. , "MEANINGFUL REDUCTION OF HEPATOCELLULAR CARCINOMA RISK IN PATIENTS WITH CHRONIC HEPATITIS C WHO RECEIVED PEGILE INTERFERON PLUS RIBAVIRIN THERAPY TWO TERTIARY CENTER EXPERIENCE," 23 rd United European Gastroenterology Week , 2015
sirin, g. Et Al. 2015. MEANINGFUL REDUCTION OF HEPATOCELLULAR CARCINOMA RISK IN PATIENTS WITH CHRONIC HEPATITIS C WHO RECEIVED PEGILE INTERFERON PLUS RIBAVIRIN THERAPY TWO TERTIARY CENTER EXPERIENCE. 23 rd United European Gastroenterology Week .
sirin, g., ŞENTÜRK, Ö., ÇELEBİ, A., YILMAZ, H., sezikli, m., & HÜLAGÜ, S., (2015). MEANINGFUL REDUCTION OF HEPATOCELLULAR CARCINOMA RISK IN PATIENTS WITH CHRONIC HEPATITIS C WHO RECEIVED PEGILE INTERFERON PLUS RIBAVIRIN THERAPY TWO TERTIARY CENTER EXPERIENCE . 23 rd United European Gastroenterology Week
sirin, goktug Et Al. "MEANINGFUL REDUCTION OF HEPATOCELLULAR CARCINOMA RISK IN PATIENTS WITH CHRONIC HEPATITIS C WHO RECEIVED PEGILE INTERFERON PLUS RIBAVIRIN THERAPY TWO TERTIARY CENTER EXPERIENCE," 23 rd United European Gastroenterology Week, 2015
sirin, goktug Et Al. "MEANINGFUL REDUCTION OF HEPATOCELLULAR CARCINOMA RISK IN PATIENTS WITH CHRONIC HEPATITIS C WHO RECEIVED PEGILE INTERFERON PLUS RIBAVIRIN THERAPY TWO TERTIARY CENTER EXPERIENCE." 23 rd United European Gastroenterology Week , 2015
sirin, g. Et Al. (2015) . "MEANINGFUL REDUCTION OF HEPATOCELLULAR CARCINOMA RISK IN PATIENTS WITH CHRONIC HEPATITIS C WHO RECEIVED PEGILE INTERFERON PLUS RIBAVIRIN THERAPY TWO TERTIARY CENTER EXPERIENCE." 23 rd United European Gastroenterology Week .
@conferencepaper{conferencepaper, author={goktug sirin Et Al. }, title={MEANINGFUL REDUCTION OF HEPATOCELLULAR CARCINOMA RISK IN PATIENTS WITH CHRONIC HEPATITIS C WHO RECEIVED PEGILE INTERFERON PLUS RIBAVIRIN THERAPY TWO TERTIARY CENTER EXPERIENCE}, congress name={23 rd United European Gastroenterology Week}, city={}, country={}, year={2015}}